Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Taillibert, F. Laigle-Donadey, M. Sanson (2004)
Palliative care in patients with primary brain tumorsCurrent Opinion in Oncology, 16
N. Litofsky, E. Farace, F. Anderson, C. Meyers, Wei Huang, E. Laws, Adam Kaplan, H. Brem, M. Berger, M. Westphal (2004)
Depression in Patients with High-grade Glioma: Results of the Glioma Outcomes ProjectNeurosurgery, 54
Stevens LM, Lynm C, Glass RM (2005)
Palliative care [JAMA Patient Page].JAMA, 293
In Reply: As a multidisciplinary group of investigators, some of whom began our careers in palliative care, we agree that the issues Dr Shannon and colleagues raise, such as relief of common symptoms like fatigue or cognitive deficits, as well as medical and psychosocial support to improve quality of life, are of critical importance to patients with brain tumors throughout their entire illness. Whether trained as surgeons, neurologists, or medical or radiation oncologists, clinicians who care for patients with brain tumors should all receive instruction in these basic principles of palliative care that are central to the care of all patients and should be familiar to all physicians.1 The declared specialty of the physician providing these aspects of care seems less important, since patients with brain tumors receive their primary treatment from members of several specialties during the course of their disease. We agree that research into symptom palliation for patients with brain tumors is a pressing need,2 and the Glioma Outcomes Project has already investigated aspects of palliative care such as depression3 in addition to those addressed in our article. Back to top Article Information Financial Disclosures: Under separate licensing agreements between the Johns Hopkins University and Guilford Pharmaceuticals Inc and the Johns Hopkins University and Angiotech Pharmaceuticals Inc, Dr Brem is entitled to a share of royalty received by the university on sales of products described in the research article. Dr Brem owns Guilford Pharmaceuticals stock, which is subject to certain restrictions under university policy. Dr Brem is also a paid consultant to Guilford Pharmaceuticals. The terms of this arrangement are being managed by the Johns Hopkins University in accordance with its conflict-of-interest policies. No other authors reported financial disclosures. References 1. Stevens LM, Lynm C, Glass RM. Palliative care [JAMA Patient Page]. JAMA. 2005;293:141015769975Google ScholarCrossref 2. Taillibert S, Laigle-Donadey F, Sanson M. Palliative care in patients with primary brain tumors. Curr Opin Oncol. 2004;16:587-59215627022Google ScholarCrossref 3. Litofsky NS, Farace E, Anderson F Jr, Meyers CA, Huang W, Laws ER Jr.Glioma Outcomes Project Investigators. Depression in patients with high-grade glioma: results of the Glioma Outcomes Project. Neurosurgery. 2004;54:358-36614744282Google ScholarCrossref
JAMA – American Medical Association
Published: May 25, 2005
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.